Patents by Inventor Jeffery Wheeler

Jeffery Wheeler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070088075
    Abstract: This invention is directed to deuterated aminocyclohexyl ether compounds and processes for preparing same and methods of using same.
    Type: Application
    Filed: October 13, 2006
    Publication date: April 19, 2007
    Applicant: Cardiome Pharma Corp.
    Inventors: Doug Chou, Bertrand Plouvier, Peter Pang, James Yee, Jeffery Wheeler, Aregahegn Yifru, Allen Davidoff
  • Publication number: 20050220779
    Abstract: Methods are provided to specifically modulate the activation of monocytes and/or macrophages. Administration of integrin linked kinase (ILK) blocking agents; compounds that otherwise prevent the binding of natural ILK ligands to ILK; or compounds that prevent expression of, or signaling through ILK exert an anti-inflammatory effect by inhibiting iNOS and COX-2 expression, at the level of transcription by suppressing the activation of NF-?B. The modulation of activation through ILK is used to regulate immune processes at targeted sites, for example to decrease undesirable inflammatory responses.
    Type: Application
    Filed: June 5, 2002
    Publication date: October 6, 2005
    Inventors: Ljiljana Kojic, Patricia Logan, Jeffery Wheeler, Kymberley Sutton, Gabriel Kalmar
  • Publication number: 20050079212
    Abstract: Plasmid-lipid particles which are useful for transfection of cells in vitro or in vivo are described. The particles can be formed using either detergent dialysis methods or methods which utilize organic solvents. The particles are typically 65-85 nm, fully encapsulate the plasmid and are serum-stable.
    Type: Application
    Filed: October 1, 2004
    Publication date: April 14, 2005
    Applicant: Inex Pharmaceuticals Corp.
    Inventors: Jeffery Wheeler, Michael Hope, Pieter Cullis, Marcel Bally
  • Patent number: 6344359
    Abstract: A rapid colorimetric assay is provided for determining the concentration of vanadyl and vanadate ion species, and total vanadium concentration, in a sample. A sample suspected of containing vanadium in one or more of these oxidation states is combined with a colorimetric substrate that will provide for different absorption spectra with vanadyl and vanadate complexes. Suitable colorimetric substrates include halogenated hydroxyquinolines, e.g. broxyquinoline (DBHQ). The solvent and assay conditions are chosen to minimize oxidation of the vanadium. The absorbance of the sample is then read at two wavelengths, one that indicates the presence of both vanadyl and vanadate, and one that indicates the presence only of one species, generally vanadate. By comparison to a standard curve, the total concentration and the species concentration of vanadium in the sample is determined.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: February 5, 2002
    Assignee: Kinetek Pharmaceuticals, Inc.
    Inventors: Jeffery Wheeler, Zaihui Zhang